Unnatural Products Inc. · 5 days ago
Full Stack Engineer
Wonder how qualified you are to the job?
Maximize your interview chances
Insider Connection @Unnatural Products Inc.
Responsibilities
Develop, test, and deploy production ready software to support scientific workflows and data analysis.
Collaborate with cross-functional teams to understand and contribute to the scope of new features.
Build and maintain software infrastructure, tools, and processes to streamline development and deployment workflows.
Develop user interfaces that enhance the capabilities of scientists to process data.
Implement software engineering best-practices, including testing, continuous deployment, and monitoring.
Participate in architectural discussions, code reviews, and knowledge sharing sessions to ensure high-quality code and maintainable systems.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor's degree in Computer Science, Engineering, Mathematics, or a Related field.
4+ years of professional experience in software development.
Significant expertise in Python programming.
Demonstrated experience in front-end development.
Skilled in Docker and Docker compose.
Expertise in AWS cloud infrastructure and Infrastructure as Code (IaC).
Curiosity and interest in scientific research, with a willingness to learn about the drug discovery process.
Preferred
Proficient in Web Development cloud infrastructure.
Skilled in Machine Learning cloud infrastructure.
Proficient in front-end development.
Experienced in software testing.
Knowledgeable about Computational Chemistry methods.
Familiar with Deep Learning methods applied to chemical structures.
Benefits
Full healthcare coverage
401k with employer contribution
Flexible time off
Continuing education stipends
Weekly team lunches
Charity matching
Company
Unnatural Products Inc.
Unlocking the potential of macrocycle drug discovery through machine learning and massively parallel synthesis
Funding
Current Stage
Early StageTotal Funding
$38MKey Investors
Artis Ventures (AV)
2023-12-19Series A· $32M
2023-09-18Series A· Undisclosed
2019-09-18Seed· $6M
Recent News
2024-04-08
The Pharma Letter
2024-04-08
Company data provided by crunchbase